Skip to content

Quantitative Differences of Proteins in Blood According to Amyloid PET / CT Positive Status in Patients with Dementia

Quantitative Differences of Proteins in Blood According to Amyloid PET / CT Positive Status in Patients with Dementia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004467
Enrollment
167
Registered
2019-11-25
Start date
2019-11-15
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults over 40 2) Patients who are taking amyloid PET / CT due to neurologic dementia specialist suspected of cognitive decline worse than MCI.

Exclusion criteria

Exclusion criteria: 1) When it is difficult to cooperate with interview and self-question (literacy, hearing impairment, speech disorder) 2) Patients who cannot consent through the patient or guardian 3) Patients with a medical condition that cannot undergo PET test History of neurological / psychiatric disorders (territorial cerebral infarction, severe head trauma, brain surgery, intracranial hematoma with permanent brain lesion, major affective disorder, schizophrenia, or schizo-affective disorder) 5) If patients are undergoing radiation therapy or are undergoing radiation exposure in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Comparison of target protein difference between positive and negative patients

Secondary

MeasureTime frame
Analyzing whether the amount of target protein reflects severity of dementia

Countries

Korea, Republic of

Contacts

Public ContactDongwoo Kim

Yonsei University Health System, Severance Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026